Literature DB >> 3971850

Heart rate variability in diabetes: relationship to age and duration of the disease.

S Masaoka, A Lev-Ran, L R Hill, G Vakil, E H Hon.   

Abstract

Heart rate variability (HRV) during deep breathing was studied with a neonatal heart monitor in 143 control subjects and 218 patients with diabetes (102 with IDDM and 116 with NIDDM). In the control group HRV decreased after age 20 by 4-5 beats per decade (from 29.7 +/- 5.8 beats at age 20-29 to 11.8 +/- 5.4 beats at age 60+). In all age groups HRV in IDDM was lower than in the controls, and both age and duration of diabetes played a role in the decrease of HRV (from 21.5 +/- 5.3 beats at age 20-29 to 6.3 +/- 5.4 at age 60+). In NIDDM aging seemed to play a less important role, and the influence of the duration of the disease was not statistically significant. In both groups of patients the frequency of HRV below the 2.5th percentile was 82% in those with symptoms and/or signs of autonomic neuropathy, 64% in patients with peripheral neuropathy only, and 36% in those who had no obvious signs or symptoms of neuropathy. Interindividual variability was pronounced, and age and duration of the disease together accounted for only 36% of the observed differences between IDDM and the controls. Determination of HRV with a standard neonatal heart monitor presents an easy, simple, and nonstressful test of cardiac autonomic neuropathy. The norms of the test are age related.

Entities:  

Mesh:

Year:  1985        PMID: 3971850     DOI: 10.2337/diacare.8.1.64

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  22 in total

1.  Quantitation of skin vasomotor control in normal subjects and in diabetic patients with autonomic neuropathy.

Authors:  A F Donk; T J Faes; D Broere; E A van der Veen; F W Bertelsmann
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

2.  Disparity of autonomic control in type 2 diabetes mellitus.

Authors:  R J Huggett; E M Scott; S G Gilbey; J Bannister; A F Mackintosh; D A S G Mary
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

3.  Asymptomatic coronary artery disease in diabetes: associated with autonomic neuropathy?

Authors:  M J Koistinen; K E Airaksinen; H V Huikuri; H Pirttiaho; M K Linnaluoto; M J Ikäheimo; J T Takkunen
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

4.  Heart rate variability in healthy subjects: effect of age and the derivation of normal ranges for tests of autonomic function.

Authors:  I A O'Brien; P O'Hare; R J Corrall
Journal:  Br Heart J       Date:  1986-04

5.  Glutamic acid decarboxylase antibodies, autonomic nerve antibodies and autonomic neuropathy in diabetic patients.

Authors:  G Sundkvist; L A Velloso; O Kämpe; S L Rabinowe; S A Ivarsson; B Lilja; F A Karlsson
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

6.  Heart rate variability in left ventricular hypertrophy.

Authors:  M K Mandawat; D R Wallbridge; S D Pringle; A A Riyami; S Latif; P W Macfarlane; A R Lorimer; S M Cobbe
Journal:  Br Heart J       Date:  1995-02

7.  Predictors of the pressor response to the clinic visit in essential hypertensives with and without diabetes mellitus.

Authors:  C L Laffer; F Elijovich
Journal:  Clin Auton Res       Date:  1994-12       Impact factor: 4.435

8.  Noradrenaline depletion in patients with coronary artery disease before and after percutaneous transluminal coronary angioplasty with iodine-123 metaiodobenzylguanidine and single-photon emission tomography.

Authors:  C Guertner; H Klepzig; F D Maul; A Hartmann; S Lelbach; A Hellmann; G Hoer
Journal:  Eur J Nucl Med       Date:  1993-09

9.  Autonomic neuropathy in asymptomatic subjects with non-insulin-dependent diabetes mellitus and microalbuminuria.

Authors:  M K Rutter; J M McComb; S Brady; S M Marshall
Journal:  Clin Auton Res       Date:  1998-10       Impact factor: 4.435

10.  Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  M Horowitz; P E Harding; A F Maddox; J M Wishart; L M Akkermans; B E Chatterton; D J Shearman
Journal:  Diabetologia       Date:  1989-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.